相似文献
1
DNA topoisomerase II and its growing repertoire of biological functions.
Nat Rev Cancer. 2009 May;9(5):327-37. doi: 10.1038/nrc2608. Epub 2009 Apr 20.
2
[Molecular determinants of response to topoisomerase II inhibitors].
Bull Cancer. 2011 Nov;98(11):1299-310. doi: 10.1684/bdc.2011.1475.
3
Topoisomerase II Poisons: Converting Essential Enzymes into Molecular Scissors.
Biochemistry. 2021 Jun 1;60(21):1630-1641. doi: 10.1021/acs.biochem.1c00240. Epub 2021 May 19.
4
[Structural, mechanistic and functional insights into topoisomerase II].
Sheng Li Xue Bao. 2016 Feb 25;68(1):98-106.
5
Targeting DNA topoisomerase II in cancer chemotherapy.
Nat Rev Cancer. 2009 May;9(5):338-50. doi: 10.1038/nrc2607. Epub 2009 Apr 20.
6
The Roles of DNA Topoisomerase IIβ in Transcription.
Int J Mol Sci. 2018 Jun 29;19(7):1917. doi: 10.3390/ijms19071917.
7
Restoration of topoisomerase 2 function by complementation of defective monomers in Drosophila.
Genetics. 2012 Nov;192(3):843-56. doi: 10.1534/genetics.112.144006. Epub 2012 Aug 24.
8
Type II DNA Topoisomerases Cause Spontaneous Double-Strand Breaks in Genomic DNA.
Genes (Basel). 2019 Oct 30;10(11):868. doi: 10.3390/genes10110868.
9
Functional and regulatory characteristics of eukaryotic type II DNA topoisomerase.
Crit Rev Biochem Mol Biol. 2001;36(1):1-37. doi: 10.1080/20014091074165.
10
TDP2 suppresses chromosomal translocations induced by DNA topoisomerase II during gene transcription.
Nat Commun. 2017 Aug 10;8(1):233. doi: 10.1038/s41467-017-00307-y.
引用本文的文献
1
Functional interplay between condensin I and topoisomerase Iiα in single-molecule DNA compaction.
Nat Commun. 2025 Aug 6;16(1):7239. doi: 10.1038/s41467-025-62600-5.
2
Unraveling the Role of Topoisomerase 3β (TOP3B) in mRNA Translation and Human Disease.
Wiley Interdiscip Rev RNA. 2025 Jul-Aug;16(4):e70020. doi: 10.1002/wrna.70020.
3
Ciprofloxacin Exerts Anti-Tumor Effects In Vivo Through cGAS-STING Activation and Modulates Tumor Microenvironment.
Cells. 2025 Jul 2;14(13):1010. doi: 10.3390/cells14131010.
4
Multi-omics and experimental validation reveal mechanism of compound mylabris capsules in treating diffuse large B-cell lymphoma.
Sci Rep. 2025 Jul 4;15(1):23856. doi: 10.1038/s41598-025-09767-5.
5
ATP-competitive inhibitors for cancer treatment - kinases and the world beyond.
RSC Med Chem. 2025 Jun 25. doi: 10.1039/d5md00235d.
6
Nonredundant roles of topoisomerase 2α and 2β in the cytosolic replication of vaccinia virus.
Nucleic Acids Res. 2025 Jun 20;53(12). doi: 10.1093/nar/gkaf566.
7
Double strand breaks drive toxicity in Huntington's disease mice with or without somatic expansion.
bioRxiv. 2025 May 28:2025.05.27.654663. doi: 10.1101/2025.05.27.654663.
8
Tetrahydropyrido[4,3-d]pyrimidines as a new active scaffold for human topoisomerase II inhibitors.
Sci Rep. 2025 Jun 4;15(1):19618. doi: 10.1038/s41598-025-04773-z.
9
Analyzing Topoisomerase II Cleavage Complexes Using Flow Cytometry.
Methods Mol Biol. 2025;2928:187-195. doi: 10.1007/978-1-0716-4550-5_15.
10
Topoisomerase II N-terminal ATPase Clamp Stabilization.
Methods Mol Biol. 2025;2928:115-122. doi: 10.1007/978-1-0716-4550-5_11.
本文引用的文献
1
DNA topoisomerases: harnessing and constraining energy to govern chromosome topology.
Q Rev Biophys. 2008 Feb;41(1):41-101. doi: 10.1017/S003358350800468X.
2
Interaction between tumor suppressor adenomatous polyposis coli and topoisomerase IIalpha: implication for the G2/M transition.
Mol Biol Cell. 2008 Oct;19(10):4076-85. doi: 10.1091/mbc.e07-12-1296. Epub 2008 Jul 16.
3
Topoisomerase II inactivation prevents the completion of DNA replication in budding yeast.
Mol Cell. 2008 Jun 20;30(6):790-802. doi: 10.1016/j.molcel.2008.04.019.
4
Chromosome cohesion - rings, knots, orcs and fellowship.
J Cell Sci. 2008 Jul 1;121(Pt 13):2107-14. doi: 10.1242/jcs.029132.
5
Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.
Cell. 2008 Apr 4;133(1):103-15. doi: 10.1016/j.cell.2008.01.045.
6
RanBP2: a tumor suppressor with a new twist on TopoII, SUMO, and centromeres.
Cancer Cell. 2008 Apr;13(4):293-5. doi: 10.1016/j.ccr.2008.03.011.
7
A topoisomerase II-dependent mechanism for resetting replicons at the S-M-phase transition.
Genes Dev. 2008 Apr 1;22(7):860-5. doi: 10.1101/gad.445108.
8
Conjugation of human topoisomerase 2 alpha with small ubiquitin-like modifiers 2/3 in response to topoisomerase inhibitors: cell cycle stage and chromosome domain specificity.
Cancer Res. 2008 Apr 1;68(7):2409-18. doi: 10.1158/0008-5472.CAN-07-2092.
9
Topoisomerase IIbeta negatively modulates retinoic acid receptor alpha function: a novel mechanism of retinoic acid resistance.
Mol Cell Biol. 2008 Mar;28(6):2066-77. doi: 10.1128/MCB.01576-07. Epub 2008 Jan 22.
10
Plk1-dependent phosphorylation regulates functions of DNA topoisomerase IIalpha in cell cycle progression.
J Biol Chem. 2008 Mar 7;283(10):6209-21. doi: 10.1074/jbc.M709007200. Epub 2008 Jan 2.
Zotero 插件